Featured/ SPRB/ 10/06/2025 · 8:50 AM Spruce Biosciences Stock Soars after Receiving FDA Breakthrough Therapy Status FDA gave a new drug Breakthrough status to treat fatal Sanfilippo Syndrome B (MPS IIIB), potentially stopping brain damage in kids.
